GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
-
Canaccord Genuity's 45th Annual Growth Conference
Boston, Massachusetts
Fireside chat: Tuesday, August 12 at 8:00 a.m. ET
-
2025 Wells Fargo Healthcare Conference
Boston, Massachusetts
Fireside chat: Thursday, September 4 at 2:15 p.m. ET
-
Morgan Stanley 23rd Annual Global Healthcare Conference
New York, New York
Fireside chat: Monday, September 8 at 8:30 a.m. ET
Live and archived webcasts of the presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250806808775/en/
Contacts
Investor Relations:
Investors@GeneDx.com
Media:
Press@GeneDx.com